The metabolic syndrome - Pathogenesis, clinical features and management
dc.contributor.author | Lombard L. | |
dc.contributor.author | Augustyn M.N. | |
dc.contributor.author | Ascott-Evans B.H. | |
dc.date.accessioned | 2011-05-15T16:15:54Z | |
dc.date.available | 2011-05-15T16:15:54Z | |
dc.date.issued | 2002 | |
dc.description.abstract | The metabolic syndrome is a highly prevalent clinical entity, which is often overlooked and may have far-reaching health implications for the patient. Up to 80% of patients with the metabolic syndrome die as a result of cardiovascular complications. Insulin resistance is the central component of this complex syndrome and should be appropriately addressed to ensure the best possible outcome for our patients. Recent advances in the pathogenesis and management of this syndrome is discussed in this article. | |
dc.description.version | Review | |
dc.identifier.citation | Cardiovascular Journal of South Africa | |
dc.identifier.citation | 13 | |
dc.identifier.citation | 4 | |
dc.identifier.issn | 10159657 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13544 | |
dc.subject | antilipemic agent | |
dc.subject | beta adrenergic receptor blocking agent | |
dc.subject | calcium channel blocking agent | |
dc.subject | dipeptidyl carboxypeptidase inhibitor | |
dc.subject | diuretic agent | |
dc.subject | fibric acid derivative | |
dc.subject | fish oil | |
dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | |
dc.subject | metformin | |
dc.subject | nicotinic acid | |
dc.subject | omega 3 fatty acid | |
dc.subject | pioglitazone | |
dc.subject | rosiglitazone | |
dc.subject | cardiovascular disease | |
dc.subject | clinical feature | |
dc.subject | diabetes mellitus | |
dc.subject | dyslipidemia | |
dc.subject | human | |
dc.subject | hyperinsulinemia | |
dc.subject | hypertension | |
dc.subject | hyperuricemia | |
dc.subject | insulin resistance | |
dc.subject | lifestyle | |
dc.subject | metabolic disorder | |
dc.subject | obesity | |
dc.subject | pathogenesis | |
dc.subject | review | |
dc.subject | risk factor | |
dc.subject | Humans | |
dc.subject | Metabolic Syndrome X | |
dc.title | The metabolic syndrome - Pathogenesis, clinical features and management | |
dc.type | Review |